
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PIPK I α CRISPR/Cas9 KO Plasmid (h) | sc-403490 | 20 µg | $397.00 |
PIP5K1A encodes phosphatidylinositol-4-phosphate 5-kinase type I alpha (PIPK I α), a key lipid kinase that generates phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) at the plasma membrane and endomembranes. By controlling PI(4,5)P2 availability, PIPK I α regulates actin cytoskeleton remodeling, clathrin-mediated endocytosis, focal adhesion dynamics, and coupling of receptor signaling to downstream pathways such as PLC and PI3K. PIP5K1A-dependent phosphoinositide signaling influences membrane trafficking and cell migration, processes frequently perturbed in tumor biology and invasive phenotypes. Altered PIP5K1A activity has also been linked to dysregulated growth factor signaling and inflammatory responses, supporting its relevance in mechanistic studies of disease-associated cellular behavior.
PIPK I α CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the PIP5K1A gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the PIP5K1A together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the PIP5K1A open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PIPK I α protein expression.
This CRISPR knockout system enables efficient generation of PIP5K1A-deficient cell models for investigation of PIPK I α signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.